ASMANEX HFA (Page 6 of 8)

16.2 Storage and Handling

Only use the ASMANEX HFA canister with the ASMANEX HFA actuator. Do not use the ASMANEX HFA actuator with any other inhalation drug product. Do not use actuators from other products with the ASMANEX HFA canister.

Do not remove the canister from the actuator because the correct amount of medication may not be discharged; the dose counter may not function properly; reinsertion may cause the dose counter to count down by 1 and discharge a puff.

The correct amount of medication in each inhalation cannot be ensured after the labeled number of actuations from the canister has been used, even though the inhaler may not feel completely empty and may continue to operate. Discard the inhaler when the labeled number of actuations has been used (the dose counter will read “0”).

Store at controlled room temperature 20°C-25°C (68°F-77°F); excursions permitted to 15°C-30°C (59°F-86°F) [see USP Controlled Room Temperature].

For best results, keep the canister at room temperature before use. Shake well and remove the cap from the mouthpiece of the actuator before using. Keep out of reach of children. Avoid spraying in eyes.

Contents Under Pressure: Do not puncture. Do not use or store near heat or open flame. Exposure to temperatures above 120°F may cause bursting. Never throw container into fire or incinerator.

17 PATIENT COUNSELING INFORMATION

Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use).

Not for Acute Symptoms

Advise patients that ASMANEX HFA is not indicated to relieve acute asthma symptoms, and extra doses should not be used for that purpose. ASMANEX HFA is not a bronchodilator and should not be used to treat status asthmaticus or to relieve acute asthma symptoms. Treat acute asthma symptoms with an inhaled, short-acting beta2 -agonist such as albuterol. Prescribe the patient with such medication and instruct the patient on how to use it [see Warnings and Precautions (5.1)].

Instruct patients to seek medical attention immediately if they experience any of the following:

  • If their symptoms worsen
  • Significant decrease in lung function as outlined by the physician
  • If they need more inhalations of a short-acting beta2 -agonist than usual

Advise patients not to increase the dose or frequency of ASMANEX HFA. Do not exceed the daily dosage of ASMANEX HFA two inhalations twice daily. If they miss a dose, instruct patients to take their next dose at the same time they normally do.

Advise patients not to stop or reduce ASMANEX HFA therapy without physician/provider guidance since symptoms may recur after discontinuation.

Local Effects

Advise patients that localized infections with Candida albicans occurred in the mouth and pharynx in some patients. If oropharyngeal candidiasis develops, treat with appropriate local or systemic (i.e., oral) antifungal therapy while still continuing with ASMANEX HFA therapy, but at times therapy with ASMANEX HFA may need to be temporarily interrupted under close medical supervision. After dosing, advise patients to rinse their mouth with water and spit out contents without swallowing [see Warnings and Precautions (5.2)].

Immunosuppression

Warn patients who are on immunosuppressant doses of corticosteroids to avoid exposure to chickenpox or measles and, if exposed, to consult their physician without delay. Inform patients of potential worsening of existing tuberculosis, fungal, bacterial, viral, or parasitic infections, or ocular herpes simplex [see Warnings and Precautions (5.3)].

Hypercorticism and Adrenal Suppression

Advise patients that ASMANEX HFA may cause systemic corticosteroid effects of hypercorticism and adrenal suppression. Additionally, instruct patients that deaths due to adrenal insufficiency have occurred during and after transfer from systemic corticosteroids. Instruct patients to slowly taper from systemic corticosteroids if transferring to ASMANEX HFA [see Warnings and Precautions (5.4 and 5.5)].

Reduction in Bone Mineral Density

Advise patients who are at an increased risk for decreased BMD that the use of corticosteroids may pose an additional risk and should be monitored and, where appropriate, be treated for this condition [see Warnings and Precautions (5.9)].

Reduced Growth Velocity

Inform patients that orally inhaled corticosteroids, including ASMANEX HFA, may cause a reduction in growth velocity when administered to pediatric patients. Physicians should closely follow the growth of pediatric patients taking corticosteroids by any route [see Warnings and Precautions (5.10)].

Glaucoma and Cataracts

Advise patients that long-term use of inhaled corticosteroids may increase the risk of some eye problems (glaucoma or cataracts); consider regular eye examinations [see Warnings and Precautions (5.11)].

Hypersensitivity Reactions Including Anaphylaxis

Advise patients that hypersensitivity reactions, such as urticaria, flushing, allergic dermatitis, bronchospasm, rash, pruritus, angioedema, and anaphylactic reaction, may occur after administration of ASMANEX HFA. Instruct patients to discontinue ASMANEX HFA if such reactions occur [see Warnings and Precautions (5.8)].

Use Daily for Best Effect

Advise patients to use ASMANEX HFA at regular intervals, since its effectiveness depends on regular use. Maximum benefit may not be achieved for 1 week or longer after starting treatment. If symptoms do not improve after 2 weeks of therapy or if the condition worsens, instruct patients to contact their physician.

Instructions for Use

Instruct patients regarding the following:

  • Read the Patient Information before use and follow the Instructions for Use carefully.
  • Remind patients to:
    • Remove the cap from the mouthpiece of the actuator before use.
    • After dosing, rinse their mouth with water and spit out contents without swallowing. This will help reduce the risk of oropharyngeal candidiasis.
    • Not remove the canister from the actuator.
    • Not wash inhaler in water. The mouthpiece should be cleaned using a dry wipe after every 7 days of use.

Manufactured for: Organon LLC, a subsidiary of
ORGANON & Co.,
Jersey City, NJ 07302, USA

Manufactured by: Kindeva Drug Delivery Limited, Loughborough, United Kingdom.

For patent information: www.organon.com/our-solutions/patent/

Copyright © 2021 Organon Global Inc. All rights reserved.

uspi-og0887-ao-2106r000

Patient InformationASMANEX® HFA (AZ-ma-neks) 50 mcg ASMANEX® HFA 100 mcgASMANEX® HFA 200 mcg (mometasone furoate) Inhalation Aerosol
This Patient Information has been approved by the U.S. Food and Drug Administration. Revised Date: 6/2021
What is ASMANEX HFA? ASMANEX HFA is an inhaled corticosteroid (ICS) prescription medicine used as maintenance treatment for the prevention and control of asthma symptoms in people 5 years of age and older.
  • ASMANEX HFA is not used to treat sudden severe symptoms of asthma.
  • ASMANEX HFA should not be used as a rescue inhaler.
  • It is not known if ASMANEX HFA is safe and effective in children less than 5 years of age.
Who should not use ASMANEX HFA?Do not use ASMANEX HFA:
  • to treat sudden severe symptoms of asthma.
  • if you are allergic to mometasone furoate or any of the ingredients in ASMANEX HFA. See the end of this Patient Information leaflet for a complete list of ingredients in ASMANEX HFA.
What should I tell my doctor before and during treatment with ASMANEX HFA?Before you use ASMANEX HFA, tell your healthcare provider if you:
  • have liver problems.
  • have osteoporosis.
  • have an immune system problem.
  • have eye problems such as increased pressure in the eye, glaucoma, cataracts, blurred vision, or other changes in your vision.
  • are allergic to any medicines.
  • are exposed to chickenpox or measles.
  • have or had tuberculosis (TB).
  • have any other medical problems.
  • are pregnant or planning to become pregnant. It is not known if ASMANEX HFA may harm your unborn baby.
  • are breastfeeding. It is not known if ASMANEX HFA passes into your breast milk and if it can harm your baby. You and your healthcare provider should decide if you will either take ASMANEX HFA or breastfeed.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. ASMANEX HFA may affect the way other medicines work, and other medicines may affect how ASMANEX HFA works.Especially, tell your healthcare provider if you take antifungal medicines, antibiotic medicines, or anti-HIV medicines such as:
  • ritonavir
  • atazanavir
  • cobicistat-containing products
  • ketoconazole
  • clarithromycin
  • nefazodone
  • saquinavir
  • nelfinavir
  • telithromycin
  • indinavir
  • itraconazole
Ask your healthcare provider if you are not sure if any of your medicines are the kinds listed above.For some medicines (including medicines for HIV such as ritonavir, cobicistat-containing products, and certain antifungals and antibiotics) your doctor may wish to monitor you carefully. Know the medicines you take. Keep a list and show it to your healthcare provider and pharmacist each time you get a new medicine.
How should I use ASMANEX HFA?Read the step-by-step instructions for using ASMANEX HFA in the Instructions for Use.
  • Use ASMANEX HFA exactly as prescribed. Do not use ASMANEX HFA more often than prescribed.
  • You must use ASMANEX HFA regularly. It may take 1 week or longer after you start using ASMANEX HFA for your asthma symptoms to get better. Do not stop using ASMANEX HFA even if you are feeling better, unless your healthcare provider tells you to.
  • Do not change or stop using ASMANEX HFA or other asthma medicines used to control or treat your breathing problems unless told to do so by your healthcare provider. Your healthcare provider will change your medicines as needed.
  • ASMANEX HFA comes in 3 strengths. Your healthcare provider has prescribed the strength that is best for you. Pay attention to the differences between ASMANEX HFA and your other inhaled medicines, including their prescribed use and the way they look.
  • For children aged 5 to less than 12 years, use ASMANEX HFA 50 mcg.
  • For adults and adolescents 12 years of age and older, use ASMANEX HFA 100 mcg or 200 mcg.
  • Take ASMANEX HFA every day, with 2 puffs in the morning and 2 puffs in the evening.
  • If you miss a dose of ASMANEX HFA, skip your missed dose and take your next dose at your regular time. Do not take ASMANEX HFA more often or use more puffs than you have been prescribed.
  • If you take more ASMANEX HFA than your healthcare provider has prescribed, call your healthcare provider right away.
  • ASMANEX HFA does not relieve sudden asthma symptoms. Always have a rescue inhaler with you to treat sudden symptoms. Use your rescue inhaler if you have breathing problems between doses of ASMANEX HFA. If you do not have a rescue inhaler, call your healthcare provider to have a rescue inhaler prescribed for you.
  • Do not use the ASMANEX HFA canister or actuator with any other medicines. Do not use any other medicine canister or actuator with ASMANEX HFA.
  • Rinse your mouth with water after each dose (2 puffs) of ASMANEX HFA. Spit out the water. Do not swallow it. This will help to lessen the chance of getting a yeast infection (thrush) in your mouth and throat.
  • Do not spray ASMANEX HFA in your eyes. If you accidentally get ASMANEX HFA in your eyes, rinse your eyes with water and if redness or irritation continues, call your healthcare provider.
  • Call your healthcare provider or get medical care right away if:
    • your breathing problems worsen with ASMANEX HFA
    • you need to use your rescue inhaler more often than usual
    • your rescue inhaler does not work as well for you at relieving symptoms
    • you need to use 4 or more inhalations of your rescue inhaler for 2 or more days in a row
    • you use 1 whole canister of your rescue inhaler within 8 weeks
    • your peak flow meter results decrease. Your healthcare provider will tell you the numbers that are right for you.
    • you have asthma and your symptoms do not improve after using ASMANEX HFA regularly for 1 to 2 weeks
What are the possible side effects of ASMANEX HFA?ASMANEX HFA can cause serious side effects, including
  • Thrush in your mouth and throat. You may develop thrush, a yeast infection (Candida albicans), in your mouth or throat. After each dose (2 puffs) of ASMANEX HFA, rinse your mouth with water. Spit out the water. Do not swallow it. This will help to prevent thrush in your mouth or throat.
  • Immune system effects and a higher chance for infections. Tell your healthcare provider about any signs of infection such as:
  • fever
  • feeling tired
  • body aches
  • vomiting
  • pain
  • nausea
  • chills
  • Adrenal insufficiency that can lead to death can happen when you stop taking oral corticosteroid medicines and start using inhaled corticosteroid medicines. Adrenal insufficiency can also happen in people who take higher doses of ASMANEX HFA than recommended over a long period of time. When your body is under stress such as from fever, trauma (such as a car accident), infection, or surgery, adrenal insufficiency can get worse. Symptoms of adrenal insufficiency include:
  • feeling tired or exhausted (fatigue)
  • weakness
  • lack of energy
  • nausea and vomiting
  • low blood pressure (hypotension)
  • dizziness or feeling faint
  • Increased wheezing right after taking ASMANEX HFA. Always have a rescue inhaler with you to treat sudden wheezing.
  • Serious allergic reactions. Stop taking ASMANEX HFA and call your healthcare provider or get emergency medical care right away if you get any of the following symptoms of a serious allergic reaction:
  • rash
  • hives
  • swelling, including swelling of the face, mouth, and tongue
  • breathing problems
  • Lower bone mineral density. This may be a problem for people who already have a higher chance for low bone density (osteoporosis).
  • Slowed growth in children. A child’s growth should be checked often.
  • Eye problems including glaucoma, cataracts, and blurred vision. You should have regular eye exams while using ASMANEX HFA.
The most common side effects reported while using ASMANEX HFA include:
  • inflammation of the nose and throat (nasopharyngitis)
  • inflammation of the sinuses (sinusitis)
  • headache
  • bronchitis
  • flu infection (influenza)
Other side effects: Worsening asthma or sudden asthma attacks have been reported with the use of inhaled mometasone furoate. Tell your healthcare provider about any side effect that bothers you or that does not go away.These are not all the side effects with ASMANEX HFA. Ask your healthcare provider or pharmacist for more information.Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How should I store ASMANEX HFA?
  • Store ASMANEX HFA at room temperature between 68°F to 77°F (20°C to 25°C).
  • The contents of your ASMANEX HFA are under pressure. Do not puncture. Do not use or store near heat or open flame. Storage above 120°F may cause the canister to burst.
  • Do not throw container into fire or incinerator.
  • Keep ASMANEX HFA and all medicines out of the reach of children.
General Information about the safe and effective use of ASMANEX HFA. Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use ASMANEX HFA for a condition for which it was not prescribed. Do not give your ASMANEX HFA to other people, even if they have the same condition that you have. It may harm them.This Patient Information leaflet summarizes the most important information about ASMANEX HFA. If you would like more information, talk with your healthcare provider. You can ask your healthcare provider or pharmacist for information about ASMANEX HFA that was written for healthcare professionals.For more information about ASMANEX HFA go to www.ASMANEX.com, or to report side effects call 1-844-674-3200.
What are the ingredients in ASMANEX HFA? Active ingredient: mometasone furoate Inactive ingredients: hydrofluoroalkane (HFA-227: 1,1,1,2,3,3,3-heptafluoropropane), ethanol and oleic acid

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.